KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
Clinical trial NCT03596723 · TERMINATED
Trial details
- NCT number
- NCT03596723
- Sponsor
- Kala Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-03
- Primary completion
- 2018-09-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.